ArticleCureus2025
Low-Dose Prednisolone for the Prevention of Recurrent Relapses in Nephrotic Syndrome Triggered by Regular Hospital Visits: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hospital visits causing psychological stress can trigger nephrotic syndrome relapse in children. While there are reports on preventing relapse during respiratory infections by using low-dose steroids, no reports exist on preventing relapse from other triggers. We describe a case of a patient with repeated relapses triggered by regular hospital visits, which were successfully prevented by administering low-dose prednisolone before the visits. A 14-year-old boy with steroid-dependent nephrotic syndrome was referred and started on mycophenolate mofetil. During the following 14 months, there were nine regular hospital visits. Up to the third of four relapses, urinary proteins appeared on the day of the hospital visit and five and three days before the hospital visit. He experienced two instances of transient proteinuria, with positive urine protein test results on the day of a regular visit. Regular hospital visits were judged to trigger a relapse. At age 16, he was started on prednisolone at 20 mg (approximately 15 mg/m² or 0.5 mg/kg) for prophylaxis five days before regular hospital visits. Thereafter, he no longer experienced relapse or transient proteinuria. However, at age 19, he experienced a relapse related to a hospital visit despite prophylaxis with prednisolone. Since regular hospital visits were discontinued and he was placed under the regular care of a local doctor, prophylactic administration of prednisolone before hospital visits was discontinued. Thereafter, the mycophenolate mofetil dose was tapered off when he was 20 years old. He did not experience a relapse again until age 23. The case shows that low-dose prednisolone administration can prevent hospital visit-related relapse as well as relapse during respiratory infections.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.